Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
8.78
+0.38 (4.52%)
At close: Mar 6, 2026, 4:00 PM EST
9.38
+0.60 (6.83%)
Pre-market: Mar 9, 2026, 7:00 AM EST

Viemed Healthcare Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
270.28224.26183.01138.83117.06
Revenue Growth (YoY)
20.52%22.54%31.82%18.60%-10.85%
Cost of Revenue
114.8291.0570.2354.1543.65
Gross Profit
155.46133.2112.7884.6873.41
Selling, General & Admin
130.5112.4893.7373.3660.04
Depreciation & Amortization Expenses
1.491.481.391.010.85
Research & Development
3.023.072.782.72.11
Other Operating Expenses
-2.49-1.730.55-0.64-1.17
Total Operating Expenses
132.51115.398.4576.4361.83
Operating Income
22.9517.914.338.2511.58
Interest Income
--0.950.490.941.24
Interest Expense
1.180.780.420.20.32
Total Non-Operating Income (Expense)
1.18-0.180.911.131.56
Pretax Income
21.7716.1714.398.9912.5
Provision for Income Taxes
6.394.764.152.773.38
Net Income
14.9311.2710.246.229.13
Minority Interest in Earnings
0.440.14---
Net Income to Common
14.9311.2710.246.229.13
Net Income Growth
32.57%9.98%64.63%-31.82%-71.06%
Shares Outstanding (Basic)
3939383939
Shares Outstanding (Diluted)
4141404041
Shares Change (YoY)
0.05%1.05%1.44%-2.15%0.38%
EPS (Basic)
0.380.290.270.160.23
EPS (Diluted)
0.370.280.250.160.22
EPS Growth
32.14%12.00%56.25%-27.27%-71.80%
Free Cash Flow
11.931.3219.124.852.75
Free Cash Flow Growth
805.24%-93.11%294.21%76.30%-87.53%
Free Cash Flow Per Share
0.290.030.470.120.07
Gross Margin
57.52%59.40%61.63%60.99%62.71%
Operating Margin
8.49%7.98%7.83%5.94%9.89%
Profit Margin
5.69%5.09%5.60%4.48%7.80%
FCF Margin
4.41%0.59%10.45%3.49%2.35%
EBITDA
51.5643.2736.1923.8822.89
EBITDA Margin
19.08%19.29%19.78%17.20%19.56%
EBIT
22.9517.914.338.2511.58
EBIT Margin
8.49%7.98%7.83%5.94%9.89%
Effective Tax Rate
29.36%29.44%28.82%30.79%27.01%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q